Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade

被引:2
作者
Catena, Xavier [1 ]
Contreras-Alcalde, Marta [1 ]
Juan-Larrea, Naiara [1 ]
Cerezo-Wallis, Daniela [1 ,8 ]
Calvo, Tonantzin G. [1 ]
Mucientes, Cynthia [1 ]
Olmeda, David [1 ,9 ]
Suarez, Javier [1 ]
Oterino-Sogo, Sergio [1 ]
Martinez, Lola [2 ]
Megias, Diego [3 ]
Sancho, David [4 ]
Tejedo, Cristina [1 ]
Frago, Susana [1 ]
Dudziak, Diana [5 ,6 ]
Seretis, Athanasios [7 ]
Stoitzner, Patrizia [7 ]
Soengas, Maria S. [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Melanoma Lab, Madrid, Spain
[2] Spanish Natl Canc Res Ctr CNIO, Biotechnol Programme, Flow Cytometry Core Unit, Madrid, Spain
[3] Inst salud Carlos ISCIII 3, Adv Opt Microscopy unit, Majadahonda, Spain
[4] Ctr Nacl Invest Cardiovasc CN, Immunobiol Lab, Madrid, Spain
[5] Friedrich Schiller Univ, Jena Univ Hosp, Inst Immunol, Jena, Germany
[6] Comprehens Canc Ctr Cent Germany Jena Leipzig, Jena, Germany
[7] Med Univ Innsbruck, Dept Dermatol Venereol & Allergol, Innsbruck, Austria
[8] Yale Univ, Sch Med, New Haven, CT USA
[9] Inst Invest Biomed Sols Morreale, Madrid, Spain
基金
欧洲研究理事会;
关键词
CLINICAL-RESPONSE; THERAPY; GENERATION; RESISTANCE; REVEALS; CD8(+); CDC1;
D O I
10.1038/s43018-025-00929-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cutaneous melanomas express a high number of potential neoepitopes, yet a substantial fraction of melanomas shift into immunologically cold phenotypes. Using cellular systems, mouse models and large datasets, we identify the tumor-secreted growth factor midkine (MDK) as a multilayered inhibitor of antigen-presenting cells. Mechanistically, MDK acts systemically in primary tumors, lymph nodes and the bone marrow, promoting a STAT3-mediated impairment of differentiation, activation and function of dendritic cells (DCs), particularly, conventional type 1 DCs (cDC1s). Furthermore, MDK rewires DCs toward a tolerogenic state, impairing CD8+ T cell activation. Downregulating MDK improves DC-targeted vaccination, CD40 agonist treatment and immune checkpoint blockade in mouse models. Moreover, we present an MDK-associated signature in DCs that defines poor prognosis and immune checkpoint blockade resistance in individuals with cancer. An inverse correlation between MDK- and cDC1-associated signatures was observed in a variety of tumor types, broadening the therapeutic implications of MDK in immune-refractory malignancies.
引用
收藏
页码:682 / 701
页数:44
相关论文
共 24 条
[21]   Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer [J].
Zhang, Zhizhu ;
Richmond, Ann ;
Yan, Chi .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
[22]   Integrative Molecular and Immune Profiling in Advanced Unresectable Melanoma: Tumor Microenvironment and Peripheral PD-1+CD4+Effector Memory T-Cells as Potential Markers of Response to Immune Checkpoint Inhibitor Therapy [J].
Molina-Garcia, Manuel ;
Rojas-Lechuga, Maria Jesus ;
Moral, Teresa Torres ;
Crespi-Payeras, Francesca ;
Bague, Jaume ;
Mateu, Judit ;
Paschalidis, Nikolaos ;
de Souza, Vinicius Goncalves ;
Podlipnik, Sebastian ;
Carrera, Cristina ;
Malvehy, Josep ;
da Silva-Junior, Rui Milton Patricio ;
Puig, Susana .
CANCERS, 2025, 17 (12)
[23]   Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells [J].
Beavis, Paul A. ;
Henderson, Melissa A. ;
Giuffrida, Lauren ;
Davenport, Alexander J. ;
Petley, Emma V. ;
House, Imran G. ;
Lai, Junyun ;
Sek, Kevin ;
Milenkovski, Nicole ;
John, Liza B. ;
Mardiana, Sherly ;
Slaney, Clare Y. ;
Trapani, Joseph A. ;
Loi, Sherene ;
Kershaw, Michael H. ;
Haynes, Nicole M. ;
Darcy, Phillip K. .
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09) :1069-1081
[24]   The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis [J].
Pasquevich, Karina A. ;
Garcia Samartino, Clara ;
Coria, Lorena M. ;
Estein, Silvia M. ;
Zwerdling, Astrid ;
Ibanez, Andres E. ;
Barrionuevo, Paula ;
de Oliveira, Fernanda Souza ;
Carvalho, Natalia Barbosa ;
Borkowski, Julia ;
Oliveira, Sergio Costa ;
Warzecha, Heribert ;
Giambartolomei, Guillermo H. ;
Cassataro, Juliana .
JOURNAL OF IMMUNOLOGY, 2010, 184 (09) :5200-5212